This is a reprint of an FDA Alert. FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Recall: Firm Press Release For Immediate Release …
Read MoreMississippi Attorney General Jim Hood, who has made significant contributions to state-based efforts to protect Americans from counterfeit products, offered an attorney general’s perspective on working collaboratively with Federal agencies to fight counterfeit medicines.
Read MoreThis is a reprint of an FDA Alert. FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. December 3, 2015 Contact Consumers Julio Tapia (718) 415-2611…
Read MoreDr. Shepherd was interviewed on a local Austin radio station and described for listeners the realities of the counterfeit medication economy, and the dangers U.S. citizens face from imported medication. After William Scully, owner of the unlicensed pharmaceutical importer Medical Device King/Pharmalogical, was convicted on charges relating to his drug importation business, Bill Swail, host…
Read MoreDuring PSM’s 2014 Interchange, Howard Sklamberg, the FDA’s Deputy Commissioner for Global Regulatory Operations and Policy gave an overview of the FDA’s work in protecting the safe drug supply chain and of legislation enacted in 2012 and 2013.
Read More
Recently, conversations and debate about drug importation has reached a fever pitch. Partnership For Safe Medicines’ many coalition members want Congress to know about our concerns for the safety of American patients. The secure American drug supply chain protects American consumers from dangerous counterfeit, substandard and unsafe medicines. Any effort designed to bypass FDA controls…
Read MoreAs a coalition whose outreach and operations involve educating health care workers and patients in all fifty states, and whose membership is comprised of more than 60 organizations committed to the safety of prescription drugs and protecting U.S. consumers against counterfeit, substandard or otherwise unsafe medicines, we are deeply concerned that importation proposals will undermine America’s existing and proposed drug safety protocols.
Read MoreHear Senior Science Advisor Eric Sampson talk about the CDC Foundation’s plans to study the impact of counterfeit drugs and educate the public health community about the black market.
Read MoreUpdate: On December 13, 2017, the U.S. Court of Appeals for the Second Circuit vacated William Scully’s conviction because a lower court “declined to allow Scully to introduce evidence at his 2015 trial showing he sought legal advice about importing drugs with foreign labels from one of his lawyers.” Ultimately Scully pleaded guilty to one charge of…
Read MoreAt the 2014 Interchange, New spoke about the risk that drug diversion poses to patients who may be treated with painkillers that have been contaminated by addicts, and about the scale of drug diversion in hospitals in the United States.
Read More